🇺🇸 FDA
Patent

US 11243213

Kits and methods for prediction and treatment of preeclampsia

granted A61KA61K35/16

Quick answer

US patent 11243213 (Kits and methods for prediction and treatment of preeclampsia) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Feb 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Feb 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K35/16